VTRS

Viatris Inc.

Price

$13.91

return (12m)

p/e

-67.82

p/bv

1.37

DIVIDEND YIELD

2.76%

VTRS price

Viatris

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VTRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals VTRS

Valuation

P/E

-67.82

Sector -2.34

Industry 11.10

P/BV

1.37

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.38

Sector 2.00

Industry 1.71

EV/EBITDA

54.88

Sector -23.69

Industry -398.52

EV/EBIT

-236.81

Sector -36.60

Industry -80.73

P/EBITDA

8.14

Sector -0.10

Industry 8.30

P/EBIT

-59.25

Sector -2.08

Industry 5.69

P/Total Assets

0.55

Sector 1.18

Industry 1.57

P/Net Current Assets

-1.79

Sector -10.91

Industry -3.38

P/Working Capital

4.90

Sector 0.09

Industry 10.51

EPS

-0.26

Sector -0.93

Industry 1.10

BVPS

12.69

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

34.40%

Sector 44.28%

Industry 29.23%

EBITDA Margin

15.61%

Sector -291.45%

Industry 4.29%

EBIT Margin

-3.62%

Sector -195.44%

Industry 1.44%

Operating Margin

1.66%

Sector -25.72%

Industry 2.16%

Net Profit Margins

-2.04%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.10

Sector 0.12

Industry 0.27

Profitability

ROE

-2.02%

Sector -34.71%

Industry 6.97%

ROA

-0.80%

Sector -28.76%

Industry 2.97%

ROIC

0.00%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

2.76%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.54%

Debt

Current Ratio

1.60

Sector 1.87

Industry 1.51

Net Debt / EBITDA

18.24

Sector -2.18

Industry -1.68

Net Debt / EBIT

-78.72

Sector -0.74

Industry -7.00

Net Debt / Equity

0.68

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.85

Sector -0.64

Industry 0.35

Equity/Assets

0.40

Sector 0.43

Industry 0.46

Liabilities/Assets

0.60

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

-4.03%

Sector -

Industry -

5Y Earnings CAGR

-25.23%

Sector -

Industry -

Fundamentals VTRS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VTRS Viatris Inc.	$13.91	93.08%	2.76%	-67.82	1.37	-2.02%	-2.04%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VTRS Historical Dividends

current DY: 2.76%

5-year average DY: 3.97%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/09/2026	03/18/2026	0.12000000
Dividends	11/24/2025	12/15/2025	0.12000000
Dividends	08/22/2025	09/15/2025	0.12000000
Dividends	05/23/2025	06/16/2025	0.12000000
Dividends	03/10/2025	03/18/2025	0.12000000
Dividends	11/22/2024	12/13/2024	0.12000000
Dividends	08/23/2024	09/13/2024	0.12000000
Dividends	05/24/2024	06/14/2024	0.12000000
Dividends	03/11/2024	03/18/2024	0.12000000
Dividends	11/24/2023	12/15/2023	0.12000000
Dividends	08/24/2023	09/15/2023	0.12000000
Dividends	05/24/2023	06/16/2023	0.12000000
Dividends	03/09/2023	03/17/2023	0.12000000
Dividends	11/23/2022	12/16/2022	0.12000000
Dividends	08/24/2022	09/16/2022	0.12000000
Dividends	05/24/2022	06/16/2022	0.12000000
Dividends	02/24/2022	03/16/2022	0.12000000
Dividends	11/23/2021	12/16/2021	0.11000000
Dividends	08/24/2021	09/16/2021	0.11000000
Dividends	05/24/2021	06/16/2021	0.11000000

ABOUT Viatris

Viatris Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

12 years

Founded: 2014

1986

Time since IPO - 40 years

45.000

Employees

Viatris Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $20.11 billion, with shareholders equity totaling $14.66 billion.

The company employs approximately 45.000 people and operates in the Saúde sector, within the Produtos Farmacêuticos industry.

Over the past 12 months, Viatris Inc. reported $14.56 billion in revenue, generating net income of $-296.50 million.

Key financial metrics include a P/E ratio of -67.82, a price-to-book (P/B) ratio of 1.37, and a trailing twelve-month dividend yield of 2.76%.

The company trades under the ticker VTRS.

Market cap

$20.11 billion

Net worth

$14.66 billion

$14,657,700,000.00

Assets

$36.83 billion

$36,834,600,000.00

Total Shares Outstanding

1.16 billion

1,155,000,000

Average Daily Trading Volume

$11.04 million

$11,041,466.00

Sector

Saúde

Industry

Produtos Farmacêuticos

VTRS

VTRS revenue and profits

Financial Results VTRS

DRAG THE FRAME TO SEE MORE DATA

VTRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56